TRUE Private Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Sell
27,029
-1,368
-5% -$160K 0.3% 57
2026
Q1
$3.42M Buy
28,397
+21,203
+295% +$2.45M 0.33% 50
2025
Q4
$757K Sell
7,194
-223
-3% -$20.9K 0.08% 131
2025
Q3
$623K Buy
7,417
+462
+7% +$38.1K 0.06% 137
2025
Q2
$551K Buy
6,955
+758
+12% +$60.3K 0.06% 136
2025
Q1
$556K Buy
6,197
+696
+13% +$65K 0.07% 125
2024
Q4
$547K Sell
5,501
-49
-0.9% -$5.05K 0.07% 126
2024
Q3
$630K Sell
5,550
-87
-2% -$10.3K 0.08% 112
2024
Q2
$698K Sell
5,637
-19
-0.3% -$2.45K 0.08% 125
2024
Q1
$746K Buy
5,656
+112
+2% +$13.8K 0.09% 120
2023
Q4
$604K Sell
5,544
-225
-4% -$23.4K 0.08% 136
2023
Q3
$594K Buy
5,769
+133
+2% +$14.3K 0.08% 126
2023
Q2
$650K Sell
5,636
-750
-12% -$85.2K 0.1% 108
2023
Q1
$679K Sell
6,386
-151
-2% -$16.3K 0.1% 105
2022
Q4
$725K Sell
6,537
-1,066
-14% -$109K 0.11% 90
2022
Q3
$654K Buy
7,603
+249
+3% +$22.2K 0.1% 94
2022
Q2
$670K Sell
7,354
-607
-8% -$53.8K 0.1% 101
2022
Q1
$704K Sell
7,961
-743
-9% -$58.6K 0.1% 106
2021
Q4
$667K Buy
8,704
+760
+10% +$60.5K 0.09% 128
2021
Q3
$601K Sell
7,944
-900
-10% -$68.4K 0.09% 133
2021
Q2
$693K Sell
8,844
-2,693
-23% -$200K 0.1% 117
2021
Q1
$856K Buy
11,537
+525
+5% +$38.7K 0.14% 96
2020
Q4
$866K Sell
11,012
-1,364
-11% -$104K 0.15% 87
2020
Q3
$986K Sell
12,376
-966
-7% -$75.7K 0.17% 77
2020
Q2
$991K Buy
13,342
+427
+3% +$32.1K 0.18% 77
2020
Q1
$955K Sell
12,915
-4,489
-26% -$353K 0.2% 67
2019
Q4
$1.52M Sell
17,404
-1,547
-8% -$127K 0.23% 61
2019
Q3
$1.53M Buy
18,951
+2,042
+12% +$164K 0.26% 56
2019
Q2
$1.36M Buy
16,909
+1,569
+10% +$120K 0.23% 60
2019
Q1
$1.23M Sell
15,340
-4,113
-21% -$308K 0.23% 68
2018
Q4
$1.43M Sell
19,453
-2,442
-11% -$172K 0.25% 75
2018
Q3
$1.49M Sell
21,895
-69
-0.3% -$4.4K 0.21% 81
2018
Q2
$1.28M Buy
21,964
+1,459
+7% +$82.3K 0.2% 78
2018
Q1
$1.07M Buy
20,505
+2,384
+13% +$129K 0.18% 81
2017
Q4
$980K Buy
18,121
+2,015
+13% +$112K 0.17% 79
2017
Q3
$990K Sell
16,106
-52
-0.3% -$3.15K 0.22% 59
2017
Q2
$995K Buy
16,158
+983
+6% +$59.8K 0.23% 61
2017
Q1
$914K Sell
15,175
-931
-6% -$56.5K 0.21% 62
2016
Q4
$954K Buy
16,106
+1,863
+13% +$109K 0.23% 58
2016
Q3
$849K Sell
14,243
-1,149
-7% -$67.2K 0.27% 52
2016
Q2
$846K Buy
15,392
+51
+0.3% +$2.71K 0.28% 49
2016
Q1
$775K Buy
15,341
+7,807
+104% +$382K 0.3% 47
2015
Q4
$380K Buy
+7,534
New +$380K 0.17% 69

Other funds holding MRK

TRUE Private Wealth Advisors's MRK Position: Q2 2026 in Review

TRUE Private Wealth Advisors reduced its Merck (MRK) stake by 4.8% in Q2 2026, selling an estimated $160K and leaving 27,029 shares worth $3.47M. The position accounts for 0.3% of the portfolio, ranked #57.

TRUE Private Wealth Advisors first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • TRUE Private Wealth Advisors held 27,029 shares of Merck worth $3.47M as of Q2 2026.
  • TRUE Private Wealth Advisors sold 1,368 Merck shares in Q2 2026, an estimated $160K.
  • Merck made up 0.3% of TRUE Private Wealth Advisors's portfolio in Q2 2026, its #57 holding.
  • TRUE Private Wealth Advisors first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on TRUE Private Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.